← ANALYSTS · TIPRANKS

Patrick Dolezal · LifeSci Capital

#1287among 12,504 TipRanks analysts★★★★★★★★★★
Hits 44% 94 of 216 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating +15.1% Over a year after the rating, TipRanks’ measure
Our companies rated now 10 Buy / hold / sell: 10 / 0 / 0
Upside of the analyst’s targets +212.4% Average over 10 current targets, to the last price
The market’s answer to the ratings +8.0% Day-0 move against SPY in the rating’s direction, average over 3 upgrades, downgrades and target changes
Date · added, NYStockAction RatingPrice target Upside Move vs SPY
Oct 5on TipRanks 13:45 VTVTvTv Therapeutics · $112M Reiterated Buy $60.00 +126.1% −1.5%next day −1.5% · 5 days 0.0%
Oct 3on TipRanks Oct 5 05:10 IMMXIWMImmix Biopharma · $720M Reiterated Buy $24.00 +200.8% +4.0%next day −5.4% · 5 days −9.1%
Oct 2on TipRanks 13:35 RCKTIWMRocket Pharmaceuticals · $259M Reiterated Buy $12.00 +450.5% −1.9%next day +1.3% · 5 days −1.2%
Sep 28on TipRanks 11:45 KODIWMKodiak Sciences · $5.5B Reiterated Buy $85.00 → $145+70.6% +69.1% +178.7%next day +1.5% · 5 days +3.1%
Sep 26on TipRanks Sep 24 11:35 SRZNIWMSurrozen · $295M Assigned Buy $54.00 +130.4% +108.5%next day −12.8% · 5 days −10.5%
Sep 3on TipRanks 17:05 ACHVIWMAchieve Life Sciences · $717M Reiterated Buy $17.00 +166.5% +2.6%next day −7.1% · 5 days −13.6%
Aug 22on TipRanks Aug 20 10:55 SLGLSol-Gel Technologies · $237M Assigned Buy $195 +203.5% +0.7%next day −1.4% · 5 days −8.7%
Aug 11on TipRanks 13:14 NGNEIWMNeurogene · $479M Reiterated Buy $65.00 → $63.00−3.1% +171.0% −1.7%next day +3.0% · 5 days 0.0%
Aug 8on TipRanks Aug 6 12:50 MBXIWMMBX Biosciences, Inc. · $2.4B Assigned Buy $121 +143.9% −0.4%next day +0.4% · 5 days −1.3%
Aug 8on TipRanks Aug 5 16:45 OCSOculis Holding · $486M Reiterated Buy $45.00 → $41.00−8.9% +462.4% +2.7%next day +1.8% · 5 days +2.3%

Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗